The tumor-stromal ratio as a strong prognosticator for advanced gastric cancer patients: proposal of a new TSNM staging system
Open Access
- 16 August 2017
- journal article
- research article
- Published by Springer Nature in Journal of Gastroenterology
- Vol. 53 (5) , 606-617
Abstract
Background Insufficient attention is paid to the underlying tumor microenvironment (TME) evolution, that resulting in tumor heterogeneity and driving differences in cancer aggressiveness and treatment outcomes. The morphological evaluation of the proportion of the stroma at the most invasive part of primary tumor (tumor-stromal ratio, TSR) in cancer is gaining momentum as evidence strengthens for the clinical relevance. Methods Tissue samples from the most invasive part of the primary gastric cancer (GC) of 494 patients were analyzed for their TSR, and a new TSNM (tumor-stromal node metastasis) staging system based on patho-biological behaviors was established and assessed. Results TSR is a new and strong independent prognostic factor for GC patients. The likelihood of tumor invasion is increased significantly for patients in the stromal-high subgroup compared to those in the stromal-low subgroup (P = 0.011). The discrimination ability of TSR was not less than the TNM staging system and was better in patients with stages I and II GC. We integrated the TSR parameter into the TNM staging system and proposed a new TSNM staging system creatively. There were three new subgroups (IC, IIC, IIID). There were four major groups and 10 subgroups in the TSNM system. The difference in overall survival (OS) was statistically significant among all TSNM system (P < 0.005 for all). Deep analyses revealed well predictive performance of the TSNM (P < 0.001). Conclusions This study confirms the TSR as a TME prognostic factor for GC. TSR is a candidate TME parameter that could easily be implemented in routine pathology diagnostics, and the TSNM staging system has been established to optimize risk stratification for GC. The value of the TSNM staging system should be validated in further prospective study.Keywords
Funding Information
- Science Fund of the National Natural Science Foundation of China (81401515, 81230031)
- Fundamental Research Funds for the Central Universities of Ministry of Education of China (2042014kf0096)
- “351 talent project (Luojia Young Scholars)” of Wuhan University (413100002)
This publication has 40 references indexed in Scilit:
- Macrophages and Therapeutic Resistance in CancerCancer Cell, 2015
- The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014Annals of Oncology, 2014
- Microenvironmental regulation of tumor progression and metastasisNature Medicine, 2013
- The evolution of the cancer niche during multistage carcinogenesisNature Reviews Cancer, 2013
- Controlling escape from angiogenesis inhibitorsNature Reviews Cancer, 2012
- Patterns of cancer invasion revealed by QDs-based quantitative multiplexed imaging of tumor microenvironmentBiomaterials, 2011
- Histopathologic-Based Prognostic Factors of Colorectal Cancers Are Associated With the State of the Local Immune ReactionJournal of Clinical Oncology, 2011
- Gastric cancerThe Lancet, 2009
- The Carcinoma–Stromal Ratio of Colon Carcinoma Is an Independent Factor for Survival Compared to Lymph Node Status and Tumor StageAnalytical Cellular Pathology, 2007
- Stromal extracellular matrix reduces chemotherapy-induced apoptosis in colon cancer cell linesClinical & Experimental Metastasis, 2002